A
Über
Andreas Lindblom is the co-founder and Managing Partner at Sciety. He has over ten years of experience investing in Nordic life science. He discussed Sciety's growth strategy through market turbulence and key questions investors should ask before committing capital on the BioStock Health and Wealth podcast. He also stated that Neogap has a unique therapeutic approach in T-cell therapy, combining personalised treatment with a scalable manufacturing process.
Schwerpunkte
LifeScience, HealthTech, BioTech, Pharma
Region
📍 Ansässig in Stockholm
Verifizierte Kontakte & Outreach Agenten
Direktes E-Mail-Muster
KI Outreach Agenten Pitch Writer
Erstelle personalisierte Anschreiben basierend auf den genauen Investitionskriterien...